In The Press:
IPWATCHDOG Turns to Partner Charles R. Macedo for his Insights on SCOTUS decision in Sandoz v. Amgen over Biosimlar Drugs
Industry Reaction to SCOTUS decision in Sandoz v. Amgen By Gene Quinn Charles R. Macedo Amster Rothstein & Ebenstein LLP In Sandoz v. Amgen, the Supreme Court addressed the “plain language” of a “carefully crafted and detailed enforcement scheme” relating to “biologic” drugs. Under this complex statute that was enacted as part of ObamaCare as […]
Differing diagnoses for European and US patents. Nature Biotechnology (2017) 35(4): 334-335
Medical diagnostic patent applications in the United States and Europe face diverging fates following the Supreme Court’s decision in Mayo — See full article here